Best for gut health while travelling: Convenient sachets packed with fibre, probiotics and essential vitamins and minerals for on-the-go gut care
Pharmaceutical interventions are currently limited to the GLP-1 RA semaglutide and the THR- agonist resmetirom, both of which have shown significant clinical benefit leading to FDA approval for the treatment of MASLD with fibrosis
Quick Answer: Tirzepatide may reduce inflammatory markers like high-sensitivity C-reactive protein, though it is unclear whether this represents direct anti-inflammatory effects or secondary benefits from weight loss and improved glycemic control
Retatrutide is an investigational 39-amino-acid, fatty-acid-acylated triple agonist engineered to engage the GIP, GLP-1, and glucagon receptors from a single peptide backbone
Happy shopping
And the people actually respond to you, and its not four days later or a week later, she says